260 related articles for article (PubMed ID: 20530257)
21. NK cell-extrinsic IL-18 signaling is required for efficient NK-cell activation by vaccinia virus.
Brandstadter JD; Huang X; Yang Y
Eur J Immunol; 2014 Sep; 44(9):2659-66. PubMed ID: 24846540
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.
Ogawa T; Tsuji-Kawahara S; Yuasa T; Kinoshita S; Chikaishi T; Takamura S; Matsumura H; Seya T; Saga T; Miyazawa M
J Virol; 2011 Jun; 85(11):5423-35. PubMed ID: 21411527
[TBL] [Abstract][Full Text] [Related]
23. Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance.
Chung JJ; Markiewicz MA; Polić B; Shaw AS
PLoS One; 2014; 9(10):e110108. PubMed ID: 25333972
[TBL] [Abstract][Full Text] [Related]
24. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
25. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
Chen Y; Wei H; Sun R; Dong Z; Zhang J; Tian Z
Hepatology; 2007 Sep; 46(3):706-15. PubMed ID: 17626270
[TBL] [Abstract][Full Text] [Related]
26. NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.
Thaxton JE; Nevers T; Lippe EO; Blois SM; Saito S; Sharma S
J Immunol; 2013 Apr; 190(7):3639-47. PubMed ID: 23455498
[TBL] [Abstract][Full Text] [Related]
27. Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?
Jonjić S; Polić B; Krmpotić A
Eur J Immunol; 2008 Nov; 38(11):2952-6. PubMed ID: 18979514
[TBL] [Abstract][Full Text] [Related]
28. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.
Spada R; Rojas JM; Pérez-Yagüe S; Mulens V; Cannata-Ortiz P; Bragado R; Barber DF
J Leukoc Biol; 2015 Mar; 97(3):583-98. PubMed ID: 25583577
[TBL] [Abstract][Full Text] [Related]
29. Kupffer Cells Regulate Natural Killer Cells Via the NK group 2, Member D (NKG2D)/Retinoic Acid Early Inducible-1 (RAE-1) Interaction and Cytokines in a Primary Biliary Cholangitis Mouse Model.
Fu HY; Bao WM; Yang CX; Lai WJ; Xu JM; Yu HY; Yang YN; Tan X; Gupta AK; Tang YM
Med Sci Monit; 2020 Jun; 26():e923726. PubMed ID: 32599603
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.
Soderquest K; Walzer T; Zafirova B; Klavinskis LS; Polić B; Vivier E; Lord GM; Martín-Fontecha A
J Immunol; 2011 Mar; 186(6):3304-8. PubMed ID: 21307295
[TBL] [Abstract][Full Text] [Related]
31. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
32. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
33. Human tumor-derived exosomes down-modulate NKG2D expression.
Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
[TBL] [Abstract][Full Text] [Related]
34. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
[TBL] [Abstract][Full Text] [Related]
35. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
Front Immunol; 2018; 9():991. PubMed ID: 29867968
[TBL] [Abstract][Full Text] [Related]
36. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
37. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
38. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
[TBL] [Abstract][Full Text] [Related]
39. Costimulation of multiple NK cell activation receptors by NKG2D.
Ho EL; Carayannopoulos LN; Poursine-Laurent J; Kinder J; Plougastel B; Smith HR; Yokoyama WM
J Immunol; 2002 Oct; 169(7):3667-75. PubMed ID: 12244159
[TBL] [Abstract][Full Text] [Related]
40. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
Markiewicz MA; Carayannopoulos LN; Naidenko OV; Matsui K; Burack WR; Wise EL; Fremont DH; Allen PM; Yokoyama WM; Colonna M; Shaw AS
J Immunol; 2005 Sep; 175(5):2825-33. PubMed ID: 16116168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
